Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Now Available: Innovators Under 35 2013 See The 2013 List »

J. Joseph Kim, 32

Medicine

Viral Genomix

Viruses learned how to better infect people over millions of years of evolution; chemical engineer and MBA J. Joseph Kim is using their knowledge to fight other diseases. Kim figures touse the viruses’ strategies as the basis for new drugs for cancer and inflammatory illnesses. In 2000,after several years at Merck, Kim founded Viral Genomix in Philadelphia, for which he has raised $1 million. “Since I was in high school I wanted to start my own biotech company,” he says. His company may soon have its first drug: Kim has tinkered with a protein called vpr, which helps the HIV virus replicate, and has coaxed it to trigger cell death in more than 50 different cancer cell lines. So far, the protein has worked in laboratory cultures and in mice and macaques; Kim intends to begin testing it in human cancer patients within a year and a half. To that end, Viral Genomix has established a partnership with the University of Pennsylvania. Kim is also developing a drug based on vpr that can limit the proliferation of the immune system cells that cause rheumatoid arthritis and psoriasis.

2002 TR35 Winners

Ewan Birney

Biotechnology

Fiona Brinkman

Biotechnology

Chris Burge

Biotechnology

Benjamin Cravatt

Biotechnology

Nathaniel David

Biotechnology

Susan Hagness

Medicine

Derek Hansford

Materials

J. Joseph Kim

Medicine

Steven Laken

Medicine

Kelvin Lee

Medicine

Milan Mrksich

Materials

Stephen OConnor

Biotechnology

Alexander Olek

Biotechnology

Vijay Pande

Biotechnology

Stephen Quake

Materials

David Sabatini

Biotechnology

John Santini

Medicine

David Schaffer

Medicine

Christoph Westphal

Biotechnology

Advertisement

More Innovators Under 35: